SCHEMBL7152190

SCHEMBL7152190

CC(C)Oc1nn(-c2cccc(Oc3ccccc3)c2)c(=O)o1

nearest known ligand 0.77

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 5/20 0.77
FAAH O00519 4/20 0.61
BCHE P06276 1/20 0.55
LIPC P11150 1/20 0.55
ACHE P22303 1/20 0.55
LIPE Q05469 1/20 0.55
ABHD16A O95870 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6551376 0.87 MGLL (1.00) MGLLFAAHBCHELIPCACHE
SCHEMBL6552675 0.84 MGLL (1.00) MGLLFAAHBCHELIPCACHE
SCHEMBL7044274 0.82 MGLL (0.53) MGLLFAAHBCHELIPCACHE
SCHEMBL2855348 0.79 MGLL (0.71) MGLLFAAHBCHELIPCACHE
SCHEMBL7044899 0.78 MGLL (0.59) MGLLFAAHLIPCLIPEABHD16A
SCHEMBL6552566 0.76 MGLL (1.00) MGLLFAAHABHD16A
SCHEMBL9553638 0.73 MGLL (0.60) MGLLFAAHBCHELIPCACHE
SCHEMBL2701979 0.72 MGLL (0.61) MGLLFAAHBCHELIPCACHE
SCHEMBL6552790 0.72 MGLL (0.74) MGLLFAAHBCHELIPCACHE
SCHEMBL7044238 0.72 BCHE (0.81) MGLLFAAHBCHELIPCACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214302-B1 SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONES AND THEIR USE AS LIPASE INHIBITORS AVENTIS PHARMA GMBH (DE) 2003-10-29 EP disclosed
US-6596742-B1 Inhibitory effect on the hormone-sensitive lipase, HSL. insecticides, controlling metabolism and multistage synthesis AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-07-22 US disclosed
EP-1214302-A1 SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONES AND THEIR USE AS LIPASE INHIBITORS Aventis Pharma Deutschland GmbH (DE) 2002-06-19 EP disclosed
WO-2001017981-A1 SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONES AND THEIR USE AS LIPASE INHIBITORS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-03-15 WO disclosed